Primary Health Props - Director/PDMR Shareholding

Primary Health Properties

24/11/2025 11:00

RNS Number : 7350I

Primary Health Properties PLC

24 November 2025

 

Primary Health Properties PLC

("PHP" or the "Company"),

 

 

Director/PDMR Shareholding

 

 

The Company has been notified that the following information relating to the transaction detailed below has been filed with the FCA in accordance with Article 19(1) of the Market Abuse Regulation.

1
Details of person discharging managerial responsibilities/person closely associated
(a)
Name
Harry Hyman
2
Reason for notification
(a)
Position/Status
Non-executive Chair
(b)
Initial notification/amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
(a)
Name
Primary Health Properties PLC
(b)
LEI
213800Y5CJHXOATK7X11
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
(a)
Description of the financial instrument
Ordinary shares of 12.5p
ISIN: GB00BYRJ5J14
(b)
Nature of the transaction
Purchase by ISA under dividend re-investment plan
(c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.942
4,262
(d)
Aggregated volume price
Single transaction
£4,016.03
(e)
Date of transaction
21 November 2025
(f)
Place of transaction
London Stock Exchange (xlon)

 

For further information

Primary Health Properties PLC

 

Toby Newman, Company Secretary & Chief Legal Officer

+44(0) 7729 047 959

 

Legal Entity Identifier: 213800Y5CJHXOATK7X11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHBGBDBRGDDGUS